52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To Glipizide Plus Metformin In Improving HbA1c | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
Links shared publicly online about this topic.
- 842total visits
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To Glipizide Plus Metformin In Improving HbA1c | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
View full resource at keyvive.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, Phase 3 Clinical Trial, Glucophage, Glucotrol
Most Recently Shared on September 27, 2010 at 7:20 pm By:
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To… http://goo.gl/fb/lVEwI
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus | Business Wire
businesswire.com — “52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin” View full resource at businesswire.com
Most Recently Shared on September 25, 2010 at 7:53 am By:
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin ... http://bit.ly/9HYgGl
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus - Drugs.com MedNews
drugs.com — “Sep 24, 2010 - Bristol-Myers Squibb Company (NYSE BMY) and AstraZeneca (NYSE AZN) today announced results from a randomized, double-blind Phase 3 clinical study” View full resource at drugs.com
Most Recently Shared on September 24, 2010 at 1:05 pm By:
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metfo... http://bit.ly/accdmv #drug
Advertisement

